Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.1.221.3NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.221.3NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.1.242NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.242NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.160.9NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.160.9NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.160.19NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.160.19NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.160.12NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.160.12NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
AT.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
AT.1NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.619.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.619.1NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
P.1.12.1 (Gamma)NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
P.1.12.1 (Gamma)NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.160.22NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.160.22NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
AZ.2.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
AZ.2.1NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.260NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.260NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.456NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.456NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.160.16NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.160.16NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
AY.4.16 (Delta)NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
AY.4.16 (Delta)NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.160.11NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.160.11NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.160.10NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.160.10NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.177.71NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.177.71NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.1.445NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.445NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
AY.21 (Delta)NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
AY.21 (Delta)NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.160.20NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.160.20NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
C.5NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
C.5NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
AF.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
AF.1NWon-NGTTGCGACTACGTGATGAGG20552884928830R-21584South Korea
B.1.177.89NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-13584.2South Korea
B.1.177.89NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
M.2NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
M.2NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.1.333NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.333NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used